ABT
Abbott Laboratories · Healthcare · Medical - Devices
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +0.7% · nuevas posiciones netas -4.2% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 8.65M | $848.35M | n/a | n/a |
| Q2 2026 | 182 | 0 | 1.10B | $99.81B | +5 | −4 |
| Q1 2026 | 184 | +3 | 1.11B | $114.25B | +7 | −5 |
| Q4 2025 | 180 | +2 | 1.17B | $146.24B | +3 | n/a |
| Q3 2025 | 24 | 0 | 623.34M | $83.47B | +1 | −2 |
| Q2 2025 | 22 | 0 | 527.92M | $71.78B | +1 | −1 |
| Q1 2025 | 19 | 0 | 196.20M | $26.01B | +1 | −1 |
| Q4 2024 | 19 | -1 | 182.48M | $20.63B | n/a | −1 |
| Q3 2024 | 19 | 0 | 108.33M | $12.33B | +1 | −1 |
| Q2 2024 | 19 | n/a | 110.87M | $11.51B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 173.15M | +0.2% | $23.19B | 0.3% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (pasivo) | 141.56M | +0.2% | $18.96B | 0.3% | ▲ Add | 2 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (pasivo) | 78.23M | -0.2% | $10.48B | 0.4% | ▼ Trim | 4 | SEC ↗ |
| 4 | JPMorgan Chase ✦ | 58.77M | n/a | $7.87B | 0.3% | n/c | 1 | SEC ↗ ×42 |
| 5 | Morgan Stanley ✦ | 38.63M | n/a | $5.17B | 0.3% | n/c | 1 | SEC ↗ ×22 |
| 6 | Geode Capital Management ✦ (pasivo) | 38.54M | +0.7% | $5.14B | 0.3% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Wellington Management ✦ | 23.25M | -7.2% | $3.11B | 0.5% | ▼ Trim | 6 | SEC ↗ ×8 |
| 8 | Goldman Sachs Group ✦ | 16.13M | n/a | $2.16B | 0.3% | n/c | 1 | SEC ↗ ×6 |
| 9 | T. Rowe Price ✦ | 15.80M | +52.7% | $2.12B | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Fisher Asset Management ✦ | 12.03M | +1.4% | $1.61B | 0.6% | ▲ Add | 6 | SEC ↗ |
| 11 | Fidelity (FMR) ✦ | 11.59M | -14.5% | $1.55B | 0.1% | ▼ Trim | 2 | SEC ↗ ×7 |
| 12 | Capital World Investors ✦ | 8.93M | +0.5% | $1.20B | 0.2% | ▲ Add | 5 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 2.30M | +43.8% | $307.66M | 0.5% | ▲ Add | 6 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 1.16M | -37.8% | $154.36M | 0.1% | ▼ Trim | 6 | SEC ↗ ×6 |
| 15 | Arrowstreet Capital ✦ | 1.14M | +123.5% | $152.53M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 16 | PRIMECAP Management ✦ | 810.39K | -7.4% | $108.54M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 585.80K | Nuevo | $78.46M | 0.1% | New | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 474.83K | +180.9% | $63.60M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 119.23K | +109.6% | $15.97M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 64.59K | -17.6% | $8.65M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 39.84K | +534.5% | $5.34M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 22 | GAMCO Investors ✦ | 22.36K | -4.3% | $2.99M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | Dodge & Cox ✦ | 17.32K | 0.0% | $2.32M | 0.0% | Held | 6 | SEC ↗ |
| 24 | Harris Associates (Oakmark) ✦ | 2.05K | -1.2% | $274,041 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Citadel Advisors | $78.46M | 0.1% |
Posición cerrada
| Norges Bank | $3.03B | era 0.4% |
| Two Sigma Investments | $3.50M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 3,058 tenedores, 1.35B acciones, $133.47B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 27 acc. · $2,958
Officer, Director · 180.30K acc. · $20.95M
Officer, Director · 218.53K acc. · $25.26M
Officer · 5.85K acc. · $642,506
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología